Parametric Portfolio Associates’s Adaptive Biotechnologies ADPT Stock Holding History

Parametric Portfolio Associates’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$6.46M	Buy	465,564 +405,466	+675%	+$6.37M	﹤0.01%	1678
2021 Q4	$1.69M	Sell	60,098 -9,687	-14%	-$297K	﹤0.01%	2543
2021 Q3	$2.37M	Sell	69,785 -1,686	-2%	-$61K	﹤0.01%	2343
2021 Q2	$2.92M	Sell	71,471 -12,988	-15%	-$505K	﹤0.01%	2205
2021 Q1	$3.4M	Sell	84,459 -34,249	-29%	-$1.85M	﹤0.01%	2433
2020 Q4	$7.02M	Buy	118,708 +33,269	+39%	+$1.72M	﹤0.01%	1845
2020 Q3	$4.16M	Buy	85,439 +20,551	+32%	+$864K	﹤0.01%	2029
2020 Q2	$3.14M	Buy	64,888 +6,620	+11%	+$241K	﹤0.01%	2207
2020 Q1	$1.62M	Buy	58,268 +19,693	+51%	+$549K	﹤0.01%	2517
2019 Q4	$1.15M	Buy	38,575 +14,300	+59%	+$411K	﹤0.01%	2988
2019 Q3	$750K	Buy	+24,275	New	+$991K	﹤0.01%	3173

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Parametric Portfolio Associates's ADPT Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Adaptive Biotechnologies (ADPT) stake by 675% in Q1 2022, buying an estimated $6.37M and bringing the position to 465,564 shares worth $6.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1678.

Parametric Portfolio Associates first reported a position in ADPT in Q3 2019 and has held it in 11 quarters since. The position peaked at $7.02M in Q4 2020. 221 funds tracked by Wall St. Rank hold ADPT as of Q1 2022.

Parametric Portfolio Associates held 465,564 shares of Adaptive Biotechnologies worth $6.46M as of Q1 2022.
Parametric Portfolio Associates bought 405,466 Adaptive Biotechnologies shares in Q1 2022, an estimated $6.37M.
Adaptive Biotechnologies made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1678 holding.
Parametric Portfolio Associates first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 11 quarters since.
Parametric Portfolio Associates's Adaptive Biotechnologies position peaked at $7.02M in Q4 2020.
221 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.